Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PepsiCo and Whole Foods

This article was originally published in The Tan Sheet

Executive Summary

PepsiCo has a new "high energy protein drink" called Fuelosophy. The milk-based product contains vitamins A, B, C, D and E and is being sold in test markets including some Whole Foods stores. The drink comes in four flavors: pomegranate berry, vanilla caramel, pineapple mango and citrus blend. It does not bear the PepsiCo logo or name...

You may also be interested in...



PepsiCo gets Naked

The soft-drink giant continues adding brands targeted for health-conscious consumers with the acquisition of Naked Juice Company, which says it has achieved annual sales of more than $150 mil. primarily through grassroots marketing and sales efforts. Azusa, Calif.-based Naked, which was controlled by North Castle Partners private equity firm, produces more than 25 juice and juice-smoothie Naked selections made from fruits and nutritional boosts and without sugars or preservatives. The deal, with terms not disclosed, comes the same month PepsiCo launched Fuelosophy, a milk-based product with vitamins A, B, C, D and E that is being sold in test markets including some Whole Foods stores (1"The Tan Sheet" Nov. 20, 2006, In Brief). PepsiCo says nearly all of Naked's beverages qualify for the "Smart Spot designation" it has made for its more than 250 "products that contribute to a healthier lifestyle."...

QUOTED. 9 April 2020. Frans van Houten.

Royal Philips will make 43,000 medical ventilators by year-end for use in the US and make 2,500 more for the Strategic National Stockpile in a deal with the US government worth $646.7m. See what Philips’ CEO Frans van Houten said about it here.

COVID-19 Lock-Down: India Pharma Manufacturing Limps Along Amid Challenges

Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.

Topics

UsernamePublicRestriction

Register

PS099969

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel